{Reference Type}: Journal Article
{Title}: Burkholderia cepacia infections at sites other than the respiratory tract: A large case series from a tertiary hospital in Madurai.
{Author}: Vithiya G;Raja S;
{Journal}: Indian J Med Microbiol
{Volume}: 45
{Issue}: 0
{Year}: 2023 Sep-Oct
{Factor}: 1.347
{DOI}: 10.1016/j.ijmmb.2023.100375
{Abstract}: Sparsely reported extrapulmonary Burkholderia cepacia complex (Bcc) infections highlights the importance of this study. This was a retrospective chart review of 37 patients with extrapulmonary Bcc infections admitted between December 2019 and July 2022 in a tertiary hospital. Males accounted for 70% of cases. 78% had atleast one underlying comorbid illness. Among 37 isolates, 22 were from blood, others include exudates, urine and peritoneal fluid. Susceptibility rates of ceftazidime, meropenem, minocycline, cotrimoxazole and levofloxacin were 88, 88, 70, 65.7 and 56.7% respectively. Eleven died of septic shock and 24 patients (64.8%) had good outcomes, while two were lost to followup.